Literature DB >> 17343261

Plasma IL-6, plasma VEGF, and serum YKL-40: relationship with disease activity and radiographic progression in rheumatoid arthritis patients treated with infliximab and methotrexate.

L S Knudsen, M Ostergaard, B Baslund, E Narvestad, J Petersen, H J Nielsen, B J Ejbjerg, M Szkudlarek, J S Johansen.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2006        PMID： 17343261     DOI： 10.1080/03009740600904300

Source DB:  PubMed          Journal:  Scand J Rheumatol        ISSN： 0300-9742            Impact factor:   3.641


× No keyword cloud information.
  11 in total

1.  The chitinase-like proteins breast regression protein-39 and YKL-40 regulate hyperoxia-induced acute lung injury.

Authors:  Myung Hyun Sohn; Min-Jong Kang; Hiroshi Matsuura; Vineet Bhandari; Ning-Yuan Chen; Chun Geun Lee; Jack A Elias
Journal:  Am J Respir Crit Care Med       Date:  2010-06-17       Impact factor: 21.405

Review 2.  The role of YKL-40 in the pathogenesis of autoimmune diseases: a comprehensive review.

Authors:  Kalthoum Tizaoui; Jae Won Yang; Keum Hwa Lee; Ji Hong Kim; Minseok Kim; Sojung Yoon; Yeonwoo Jung; Joon Beom Park; Kitae An; Hyeok Choi; Donggyu Song; HyunTaek Jung; Seongmin Ahn; Taeho Yuh; Hee Min Choi; Jae Ha Ahn; Younjuong Kim; Sanghyun Jee; Hyeongsun Lee; Soohwa Jin; Jun-Gu Kang; Bohyun Koo; Joo Yeop Lee; Kyoung Min Min; Wonseok Yoo; Hyeong Jun Rhyu; Yeonjung Yoon; Min Ho Lee; Sung Eun Kim; Jimin Hwang; Ai Koyanagi; Louis Jacob; Seoyeon Park; Jae Il Shin; Lee Smith
Journal:  Int J Biol Sci       Date:  2022-05-21       Impact factor: 10.750

3.  Role of breast regression protein-39/YKL-40 in asthma and allergic responses.

Authors:  Chun Geun Lee; Jack A Elias
Journal:  Allergy Asthma Immunol Res       Date:  2009-12-30       Impact factor: 5.764

4.  C-reactive protein is an indicator of serum infliximab level in predicting loss of response in patients with Crohn's disease.

Authors:  Toshifumi Hibi; Atsushi Sakuraba; Mamoru Watanabe; Satoshi Motoya; Hiroaki Ito; Noriko Sato; Toru Yoshinari; Kenta Motegi; Yoshitaka Kinouchi; Masakazu Takazoe; Yasuo Suzuki; Takayuki Matsumoto; Kazuhiko Kawakami; Takayuki Matsumoto; Ichiro Hirata; Shinji Tanaka; Toshifumi Ashida; Toshiyuki Matsui
Journal:  J Gastroenterol       Date:  2013-04-20       Impact factor: 7.527

5.  YKL-40 in allogeneic hematopoietic cell transplantation after AML and myelodysplastic syndrome.

Authors:  B Kornblit; T Wang; S J Lee; S R Spellman; X Zhu; K Fleischhauer; C Müller; M R Verneris; K Müller; J S Johansen; L Vindelov; P Garred
Journal:  Bone Marrow Transplant       Date:  2016-07-18       Impact factor: 5.483

6.  Antigen-specific over-expression of human cartilage glycoprotein 39 on CD4+ CD25+ forkhead box protein 3+ regulatory T cells in the generation of glucose-6-phosphate isomerase-induced arthritis.

Authors:  Y Tanaka; I Matsumoto; A Inoue; N Umeda; C Takai; T Sumida
Journal:  Clin Exp Immunol       Date:  2014-08       Impact factor: 4.330

7.  Chitinase 3-like 1 is a profibrogenic factor overexpressed in the aging liver and in patients with liver cirrhosis.

Authors:  Norihisa Nishimura; Davide De Battista; David R McGivern; Ronald E Engle; Ashley Tice; Rafaelle Fares-Gusmao; Juraj Kabat; Anna Pomerenke; Hanh Nguyen; Shinya Sato; Kevin W Bock; Ian N Moore; David E Kleiner; Fausto Zamboni; Harvey J Alter; Sugantha Govindarajan; Patrizia Farci
Journal:  Proc Natl Acad Sci U S A       Date:  2021-04-27       Impact factor: 11.205

Review 8.  Recent advances in neutralizing the IL-6 pathway in arthritis.

Authors:  Charles J Malemud
Journal:  Open Access Rheumatol       Date:  2009-10-05

9.  Role of breast regression protein 39 (BRP-39)/chitinase 3-like-1 in Th2 and IL-13-induced tissue responses and apoptosis.

Authors:  Chun Geun Lee; Dominik Hartl; Gap Ryol Lee; Barbara Koller; Hiroshi Matsuura; Carla A Da Silva; Myung Hyun Sohn; Lauren Cohn; Robert J Homer; Alexander A Kozhich; Alison Humbles; Jennifer Kearley; Anthony Coyle; Geoffrey Chupp; Jennifer Reed; Richard A Flavell; Jack A Elias
Journal:  J Exp Med       Date:  2009-05-04       Impact factor: 14.307

10.  YKL-40-A Protein in the Field of Translational Medicine: A Role as a Biomarker in Cancer Patients?

Authors:  Nicolai A Schultz; Julia S Johansen
Journal:  Cancers (Basel)       Date:  2010-07-12       Impact factor: 6.639
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.